HR 2285 · 113th Congress · Health
Strategies to Address Antimicrobial Resistance Act
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the Subcommittee on Health.(2013-06-07)
Plain Language Summary
[AI summary unavailable — showing source text]
Strategies to Address Antimicrobial Resistance Act - Amends the Public Health Service Act to reauthorize through FY2018 and revise a program to combat antimicrobial resistance. Requires the Secretary of Health and Human Services (HHS) to direct the Assistant Secretary of Health to establish the Antimicrobial Resistance Office. Requires the Secretary to establish the Public Health Antimicrobial Advisory Board to advise the Director of the Office (Director). Requires the Director to update the Public Health Action Plan to Combat Antimicrobial Resistance within one year. Requires the Antimicrobial Resistance Task Force to review, discuss, and further develop the Action Plan. Authorizes the Food and Drug Administration (FDA) to consult with the Director of the Antimicrobial Resistance Office concerning the pending application of any new human or animal antimicrobial drugs. Requires the Public Health Antimicrobial Advisory Board to make recommendations to the Secretary and the Antimicrobial Resistance Office regarding issues such as research priorities and implementation of the Action Plan. Requires the Secretary, acting through the Director of the National Institutes of Health (NIH), t…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (4)
4 Democrats